| Item |
Cat. No. |
Application |
Isotype |
| Anti-LPS mAbs [M18F](MABL-2278) |
MABL-2278 |
Engineer |
Burkholderia mallei |
| Anti-LPS mAbs [CK3 (BP1 7F7)](MABL-2277) |
MABL-2277 |
Engineer |
Burkholderia pseudomallei, Burkholderia thailandensis |
| Anti-LPA-2 mAbs [scAb#05](MABL-2276) |
MABL-2276 |
Engineer |
Human |
| Anti-Lox-1 mAbs [AbAb01LOX1](MABL-2275) |
MABL-2275 |
Engineer |
Human |
| Anti-loggerhead IgY spliced chain mAbs [LH1](MABL-2274) |
MABL-2274 |
Engineer |
Green sea turtle, Kemp |
| Anti-loggerhead IgY light chain mAbs [LH9](MABL-2273) |
MABL-2273 |
Engineer |
Sea turtles |
| Anti-loggerhead IgY heavy chain mAbs [LH-12-4](MABL-2272) |
MABL-2272 |
Engineer |
Sea turtles |
| Anti-LMP1 mAbs [HLEAFab](MABL-2271) |
MABL-2271 |
Engineer |
Epstein-Barr virus |
| Anti-Livetin mAbs [3H4D7](MABL-2270) |
MABL-2270 |
Engineer |
Birds |
| Anti-Lipoteichoic acid mAbs [BSYX-A110 (Pagibaximab)](MABL-2269) |
MABL-2269 |
Engineer |
Gram Positive Bacteria |
| Anti-Lipoteichoic acid mAbs [A120](MABL-2268) |
MABL-2268 |
Engineer |
Gram Positive Bacteria |
| Anti-Lipoteichoic acid mAbs [6G9](MABL-2267) |
MABL-2267 |
Engineer |
Clostridium difficile |
| Anti-Lipoteichoic acid mAbs [4D6](MABL-2266) |
MABL-2266 |
Engineer |
Clostridium difficile |
| Anti-Lipoprotein-associated phospholipase A2 mAbs [B200](MABL-2265) |
MABL-2265 |
Engineer |
Insect |
| Anti-Lipoprotein-associated phospholipase A2 mAbs [B144](MABL-2264) |
MABL-2264 |
Engineer |
Insect |
| Anti-Lipoprotein-associated phospholipase A2 mAbs [A2-Ab2](MABL-2263) |
MABL-2263 |
Engineer |
Human |
| Anti-Lipoprotein-associated phospholipase A2 mAbs [A2-Ab1](MABL-2262) |
MABL-2262 |
Engineer |
Human |
| Anti-Lipoprotein lipase mAbs [5D2](MABL-2261) |
MABL-2261 |
Engineer |
Bovine, Cat, Chicken, Guinea Pig, Rat, Human |
| Anti-Lipopolysaccharides Ogawa and Inaba mAbs [72.1](MABL-2260) |
MABL-2260 |
Engineer |
Vibrio cholerae |
| Anti-Lipopolysaccharide mAbs [WN1 222-5](MABL-2259) |
MABL-2259 |
Engineer |
Gram-negative bacteria |
